Selection of mouse neuroblastoma cell‐specific polyoma virus mutants with stage differentiative advantages of replication

• Published in: The EMBO journal Vol. 4; no. 12; pp. 3215 - 3221
• Main Authors: Maione, R., Passananti, C., De Simone, V., Delli‐Bovi, P., Augusti‐Tocco, G., Amati, P.
• Format: Journal Article
• Language: English
• Published: England 01-12-1985
• Subjects: Animals; Base Sequence; Cell Line; Cloning, Molecular; DNA Replication; DNA Restriction Enzymes; DNA, Viral - genetics; DNA, Viral - isolation & purification; Mice; Mutation; Neuroblastoma - microbiology; Nucleic Acid Hybridization; Polyomavirus - genetics; Virus Replication
• ISSN: 0261-4189; 1460-2075
• DOI: 10.1002/j.1460-2075.1985.tb04068.x

Two mouse neuroblastoma cell lines were analyzed for their permissivity for polyoma virus growth. One (N18) is fully permissive for polyoma replication, the other (41A3) shows limited permissivity and the viral genome persists, without noticeable cell death. Virus persistence does not seem to alter the cells' ability to differentiate in vitro and leads to selection of viral mutants altered in the untranscribed regulatory region of the genome. The mutant types obtained appear to be related to the degree of host cell differentiation. Nucleotide sequence analysis of the restriction fragment covering the regulatory region shows that duplications are present in all mutants, while deletions in the non‐duplicated segment are only present in mutants selected from less differentiated cells. These alterations involve both domains of the regulatory region that are considered to be essential for DNA replication and for enhancer activity. Mixed infections with polyoma wild type show that the selected mutants have cis‐advantage in replication in neuroblastoma cells and not in 3T6 cells. Mutants carrying the deletion in the non‐duplicated segment of the enhancer show a selective advantage in replication over the undeleted one in mixed infection. This advantage is much stronger in neuroblastoma cells in suspension (less‐differentiated stage) than in monolayer cells (more‐differentiated stage). An interpretation of the overall structure of the regulatory enhancer region, based on the observed differences between the mutants selected at different stages of differentiation in neuroblastoma and previously described mutants selected in undifferentiated cells, is discussed.